---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002398"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:09:48.376919+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PAVmed stockholders approve 4x increase in authorized shares to 250M and Series C Preferred issuance

## Summary
- Stockholders approved amending the certificate of incorporation to increase authorized common shares from 50M to 250M, effective Jan 15, 2025.
- Stockholders also approved the issuance of common stock upon conversion of Series C Convertible Preferred shares.
- Series C Preferred will be issued under a Debt Exchange Agreement and a Securities Purchase Agreement, both dated November 2024.
- Company expects to consummate the Series C Preferred issuance and debt exchange by January 31, 2025.
- Vote tallies: For amendment 5.23M vs 0.72M against; for issuance 5.48M vs 0.46M against.

## SEC filing metadata
- accession: 0001493152-25-002398
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225002398/0001493152-25-002398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225002398/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002398
- JSON: https://secwatch.observer/filing/0001493152-25-002398.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002398.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.